Development of individualized medicine for epilepsy based on genetic information.

about

Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy.

P2860

Q33664128-2B4031EA-2753-4DB8-8DC8-AFF460280742

P2860

Development of individualized medicine for epilepsy based on genetic information.

Item

http://www.wikidata.org/entity/Q38178326

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Development of individualized medicine for epilepsy based on genetic information.

@en

type

Item

label

Development of individualized medicine for epilepsy based on genetic information.

@en

prefLabel

Development of individualized medicine for epilepsy based on genetic information.

@en

P1476

Development of individualized medicine for epilepsy based on genetic information.

@en

P2093

Hiroto Iwasa

http://www.w3.org/2001/XMLSchema#string

Kazuaki Kanai

http://www.w3.org/2001/XMLSchema#string

Norio Yasui-Furukori

http://www.w3.org/2001/XMLSchema#string

Shuichi Yoshida

http://www.w3.org/2001/XMLSchema#string

Sunao Kaneko

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2

CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy

A Korean kindred with autosomal dominant nocturnal frontal lobe epilepsy and mental retardation

A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy

Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias

A nonsense mutation of the MASS1 gene in a family with febrile and afebrile seizures

A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns

A potassium channel mutation in neonatal human epilepsy

Radicals r'aging.

De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy

P304

661-681

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17512433.1.5.661

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24422737

http://www.w3.org/2001/XMLSchema#string

Development of individualized medicine for epilepsy based on genetic information.

about

P2860

P2860

Development of individualized medicine for epilepsy based on genetic information.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698